Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOXL2 | Q9Y4K0 | 3/20 | 0.55 |
| ▸ | PNMT | P11086 | 1/20 | 0.54 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.54 |
| ▸ | NOS1 | P29475 | 5/20 | 0.52 |
| ▸ | NOS2 | P35228 | 5/20 | 0.52 |
| ▸ | NOS3 | P29474 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.52 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | KIF11 | P52732 | 3/20 | 0.46 |
| ▸ | NCF1 | P14598 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.43 |
| ▸ | MGLL | Q99685 | 1/20 | 0.42 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29906073 | 1.00 | LOXL2 (0.55) | LOXL2PNMTENPP2NOS1NOS2 | |
| Hydrochloric Acid SCHEMBL922121 | 0.98 | NOS1 (0.53) | LOXL2PNMTENPP2NOS1NOS2 | |
| Methane SCHEMBL27646155 | 0.95 | NOS1 (0.52) | LOXL2PNMTENPP2NOS1NOS2 | |
| SCHEMBL18822261 | 0.89 | BCL2 (0.53) | LOXL2PNMTENPP2NOS1NOS2 | |
| SCHEMBL166894 | 0.87 | TP53 (0.61) | NOS1NOS2NOS3ALDH1A1SMN1; SMN2 | |
| SCHEMBL10422276 | 0.87 | LOXL2 (0.71) | LOXL2PNMTENPP2NOS1NOS2 | |
| SCHEMBL36008 | 0.87 | LOXL2 (0.71) | LOXL2PNMTENPP2NOS1NOS2 | |
| Alcohol SCHEMBL28567542 | 0.85 | ENPP2 (0.60) | LOXL2PNMTENPP2NOS1NOS2 | |
| Propylamine SCHEMBL4356386 | 0.85 | LOXL2 (0.55) | LOXL2PNMTENPP2NOS1NOS2 | |
| Hydrazine SCHEMBL28200147 | 0.84 | TP53 (0.52) | NOS1NOS2NOS3TP53KIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 468 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1610779-B1 | 3-OXO-1,3-DIHYDRO-INDAZOLE-2-CARBOXYLIC ACID AMIDE DERIVATIVES AS PHOSPHOLIPASE INHIBITORS | LILLY CO ELI (US) | 2009-09-09 | — | — | EP | claimed |
| WO-2026105418-A1 | METHOD FOR MANUFACTURING SEMICONDUCTOR WAFER | 三菱瓦斯化学株式会社 | 2026-05-21 | — | — | WO | disclosed |
| US-12584015-B2 | Polyimide resin composition | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2026-03-24 | — | — | US | disclosed |
| EP-4696736-A1 | POLYIMIDE RESIN PRECURSOR, POLYIMIDE RESIN, AND POLYIMIDE FILM | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2026-02-18 | — | — | EP | disclosed |
| US-20260022208-A1 | POLYIMIDE RESIN, POLYIMIDE VARNISH, POLYIMIDE FILM, AND TEMPORARY FIXING MATERIAL COMPOSITION | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2026-01-22 | — | — | US | disclosed |
| US-12447717-B2 | Multilayered body and method for manufacturing same | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2025-10-21 | — | — | US | disclosed |
| EP-3882299-B1 | POLYIMIDE RESIN, VARNISH, AND POLYIMIDE FILM | MITSUBISHI GAS CHEMICAL CO (JP) | 2025-09-03 | — | — | EP | disclosed |
| EP-4588955-A1 | POLYIMIDE RESIN, POLYIMIDE VARNISH, POLYIMIDE FILM, AND TEMPORARY FIXING MATERIAL COMPOSITION | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2025-07-23 | — | — | EP | disclosed |
| CN-116096820-B | Polymer composition, varnish, and polyimide film | 三菱瓦斯化学株式会社 | 2025-06-17 | — | — | CN | disclosed |
| WO-2025121336-A1 | POLYIMIDE RESIN | 三菱瓦斯化学株式会社 | 2025-06-12 | — | — | WO | disclosed |
| US-4820816-A | 3-trifuoromethylsulfonyloxy-substituted 1-carbacephalosporins as intermediates for antibiotics | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1989-04-11 | — | — | US | disclosed |
| US-4778884-A | REACTING TRIFLUOROMETHYLSULFONYLOXY COMPOUND WITH LITHIUM HALIDE IN APROTIC POLAR SOLVENT | PRESIDENT & FELLOWS OF HARVARD COLLEGE (US) | 1988-10-18 | — | — | US | disclosed |
| US-4775752-A | Process and intermediates for beta-lactam antibiotics | THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1988-10-04 | — | — | US | disclosed |
| US-4734495-A | Process and intermediates for beta-lactam antibiotics | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1988-03-29 | — | — | US | disclosed |
| US-4673737-A | ANTIBIOTICS/ | HARVARD UNIVERSITY (US) | 1987-06-16 | — | — | US | disclosed |
| US-4665171-A | CARBACEPHALOSPORINS | HARVARD UNIVERSITY (US) | 1987-05-12 | — | — | US | disclosed |
| EP-0211540-A1 | Intermediates and process for antibiotics | THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1987-02-25 | — | — | EP | disclosed |
| CN-86105247-A | Antibiotic intermediate and preparation method | — | 1987-02-04 | — | — | CN | disclosed |
| CN-86104783-A | The method for preparing beta-Lactam antibiotics | — | 1987-02-04 | — | — | CN | disclosed |
| EP-0209352-A2 | Process and intermediates for beta-lactam antibiotics | THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1987-01-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260022208-A1 | POLYIMIDE RESIN, POLYIMIDE VARNISH, POLYIMIDE FILM, AND TEMPORARY FIXING MATERIAL COMPOSITION | SETDB1, FEM1B, F9 | LOXL2 2177/4885PNMT 2222/4885ENPP2 2339/4885 |
| US-12584015-B2 | Polyimide resin composition | PSMA1, SEM1, RIF1 | LOXL2 1379/4885PNMT 3088/4885ENPP2 2574/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.